An interventional study of Group-based Acceptance and Commitment Therapy and TAU in Depression - Major Depressive Disorder, Depression Anxiety Disorder and Anxiety, sponsored by Sorlandet Hospital HF. Recruiting at 2 sites in Norway. Open to participants aged 16 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-06-01.
Sponsored by Sorlandet Hospital HF · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 92 studies in Anxiety Disorders with a site in Norway — 22 open to participants now, 32 under way, none of them phase 3. Anxiety Disorders · Norway.
Among the 92 studies in Anxiety Disorders with a site in Norway, this one is the 27th largest by planned enrollment of the 72 interventional ones that give a count, is one of 6 that started in 2026, is one of 63 with no phase, reaches primary completion later than 27 of the 31 other live ones, and was the 88th registered.
7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.
Browse Anxiety Disorders studies →22 of the 92 studies in Anxiety Disorders with a site in Norway are open now. Recruiting first, the newest first:
Sorlandet Hospital HF · Sites in Norway
Ages 10–16
University of Oslo · Sites in Norway
Ages 16–19
Sorlandet Hospital HF · Sites in Norway
Ages 18+
Helse Stavanger HF · Sites in Norway
Ages 13–18
Haukeland University Hospital · Sites in Norway
Ages 16+
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.
This study: 16 Years to 25 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
92 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 4 · Phase 3 3 · Phase 4 1
First in 1993; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 212 is above the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.
Median enrollment 155 across the 72 interventional studies, 660 across the 20 observational. Of the 51 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 92 have an industry lead sponsor. The 10 most frequent:
Sorlandet Hospital HF is the lead sponsor of 75 studies on the registry; 13 are open to participants now.
Sorlandet Hospital HF has 6 studies filed under Anxiety Disorders — fewer than ten, so there is no comparison to draw.
7 of the studies in Anxiety Disorders with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07864324University Hospital of North NorwayHigh-Intensity Interval Training and Mental Health in Psychiatric Inpatients | 2026-12-15 |
| NCT06777693NKS Olaviken Gerontopsychiatric HospitalThe Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Older Adults: a Feasibility Study | 2026-12-24 |
| NCT07000799University of OsloA Study of School Absenteeism and Student Well-being in Elementary Schools | 2026-12-31 |
| NCT07145307Helse Stavanger HFPersonalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial | 2027-04 |
| NCT06568419Solli Distriktspsykiatriske SentereBehandling - Health and Work for Patients in Specialist Mental Health Care | 2027-04 |
Add all 7 to your calendar (.ics) → With an account.
Among the 92 studies in Anxiety Disorders with a site in Norway, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This clinical study investigates the effectiveness of two psychological treatment formats for young people aged 16-25 with symptoms of depression, anxiety, stress, or interpersonal difficulties. The study compares group-based Acceptance and Commitment Therapy (ACT) with treatment as usual (TAU), most frequent that would be individual psychotherapy, both of which are established treatment approaches.
The study uses a randomized controlled design (RCT), in which participants are randomly assigned to one of the two treatment conditions. This allows for a systematic comparison of treatment outcomes between ACT delivered in a group format and standard individual therapy.
The ACT group intervention consists of a structured program in which participants meet regularly over a defined treatment period. The treatment focuses on processes such as psychological flexibility, acceptance of internal experiences, and engagement in actions aligned with personal values.
The individual therapy condition consists of one-to-one sessions with a clinician, following standard therapeutic practice. Treatment content and duration are tailored to the participant's clinical presentation and therapeutic needs.
Outcome measures include standardized assessments of mental health symptoms, functioning, and psychological processes. These assessments are conducted at baseline, during the treatment period, at post-treatment, and at follow-up time points. Data collected from these measures will be used to evaluate changes over time and differences between the two treatment conditions.
The primary aim of the study is to determine whether group-based ACT is as effective as, or more effective than, individual psychotherapy for young people receiving mental health services. The results are expected to contribute to improved knowledge about treatment options for this age group and inform future clinical practice.
Background and Rationale Mental health problems among adolescents and young adults represent a significant and increasing public health concern. A substantial proportion of young people experience symptoms of depression, anxiety, and related psychological distress during a developmental period characterized by major psychological, social, and biological transitions. These challenges may interfere with identity development, educational attainment, and social functioning, with potential long-term consequences for health and well-being .
At the same time, mental health services face increasing demand and limited capacity, resulting in prolonged waiting times and restricted access to timely care. Traditional outpatient treatment is primarily delivered as individual psychotherapy, which limits the number of patients that can be treated. There is therefore a need to evaluate alternative and potentially more scalable treatment formats that can maintain or improve clinical outcomes while increasing accessibility.
Acceptance and Commitment Therapy (ACT) is a transdiagnostic behavioral intervention that aims to improve psychological functioning by enhancing psychological flexibility. The ability to act in accordance with personal values while remaining in contact with difficult internal experiences. Rather than focusing solely on symptom reduction, ACT targets core processes such as acceptance, cognitive defusion, present-moment awareness, values clarification, and committed action.
Although ACT has a substantial evidence base in adult populations, research on its effectiveness for young people remains more limited, particularly in routine clinical settings and in comparison with standard care. Group-based formats may represent an efficient way of delivering ACT, while also offering therapeutic benefits such as peer support, normalization, and shared learning. The present study addresses important gaps in the literature by evaluating a structured group-based ACT intervention tailored for young people, compared with treatment as usual (TAU), within specialized mental health services.
Study Objectives The primary objective of the study is to evaluate the effectiveness of group-based ACT compared with treatment as usual in reducing symptoms of depression and anxiety among young people aged 16-25.
Secondary objectives include:
Study Design
This study is a randomized controlled trial (RCT) with two parallel treatment arms:
The target sample size is 212 participants, accounting for expected attrition and ensuring adequate statistical power for both outcome and process analyses .
Participants
Inclusion criteria:
Age 16-25 years Moderate symptoms of depression, score of 14 and above in the DASS 21 questionnaire
Exclusion criteria:
Severe psychiatric conditions requiring alternative treatment (e.g., psychosis, bipolar disorder) Active substance dependence Acute suicidal ideation or behavior Eating disorders or developmental disorders requiring specialized interventions Participants with specific disorders for which established evidence-based treatments are indicated (e.g., OCD) will be offered those treatments outside the study.
Interventions:
Group-based ACT
The experimental intervention is a structured group program based on Acceptance and Commitment Therapy, adapted for young people using the DNA-V framework. The intervention focuses on developing skills in:
Treatment as Usual (TAU) Participants allocated to TAU will receive standard care within mental health services. This typically involves individual psychotherapy delivered by a clinician. The content, frequency, and duration of treatment are determined by clinical needs and routine practice, reflecting real-world conditions.
Procedures and Assessments:
Participants will undergo a baseline assessment prior to randomization, including diagnostic evaluation using structured clinical interviews. Follow-up assessments will be conducted at multiple time points:
Outcome data will be collected using a combination of clinician-administered interviews and validated self-report measures assessing:
Outcomes
Primary outcomes:
Secondary outcomes:
Process outcomes:
Statistical Analysis Data will be analyzed using appropriate statistical methods for longitudinal and randomized designs. Primary analyses will compare changes in outcome measures between treatment conditions over time.
Secondary analyses will examine:
Ethical Considerations Participation in the study is voluntary, and all participants will provide informed consent prior to inclusion. Participants may withdraw at any time without consequences for their access to treatment.
The interventions evaluated in this study are based on established therapeutic approaches and are not expected to pose significant risk. However, participation in group-based treatment may be experienced as challenging for some individuals. Measures are in place to monitor and address adverse reactions, including the presence of trained therapists and access to follow-up support .
The study will be conducted in accordance with ethical guidelines and has been approved by the regional ethics committee.
Significance This study will contribute to the evidencebase for psychological treatments for young people by evaluating a scalable, group-based intervention within routine clinical practice. The findings may inform service development and improve access to effective mental health care for this population. Additionally, the study will provide insight into the mechanisms underlying therapeutic change, supporting further refinement of interventions based on ACT principles.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants assigned to this arm will receive a structured, manualized group-based Acceptance and Commitment Therapy (ACT) intervention delivered by trained clinicians.
Other: Group-based Acceptance and Commitment Therapy
Participants assigned to this arm will receive treatment as usual consisting of standard mental health care delivered according to routine clinical practice within hospital-based specialized mental health services and, when applicable, municipal health services or student health services. The type, format, frequency, and duration of care are determined by clinical need and may vary between participants.
Other: TAU
Group-Based Acceptance and Commitment Therapy (ACT) consists of a structured, manualized group intervention delivered according to established ACT principles and tailored for young people. The intervention is provided in a group format within specialized mental health services and focuses on enhancing psychological flexibility through core ACT processes. Treatment is delivered by trained clinicians, and the group format emphasizes experiential exercises, mindfulness practices, values-based work, and peer interaction. The frequency and duration of sessions follow the study protocol.
Treatment as Usual (TAU) consists of standard mental health care provided according to routine clinical practice within hospital-based specialized mental health services, as well as through municipal health services and student health services when applicable. The type, format (e.g., individual or group-based), frequency, and duration of care are determined by clinical need and may vary between participants.
Depression, Anxiety, Stress Scale
Measures depression, anxiety and stress
Time frame: From enrollment to 1 year
Hamilton Rating Scale Depression HDRS
Measures level of depression
Time frame: From enrollment to 1 year
The Psychological Flexibility Questionnaire PSY-Flex
Questionnaire measuring Psychological Flexibility
Time frame: From enrollment to 1 year
The Structural Clinical Interview for DSM-5 Clinician Version (SCID-5-CV
Diagnostic interview SCID 5 CV
Time frame: Enrollemnt of study and after 12 months
Clinical Outcomes in Routine Evaluation (CORE-OM)
Self report about psychological symptoms
Time frame: From enrollment to 1 year
The PTSD Checklist for DSM-5 PCL-5
PCL-5 questionnaire, symptoms of PTSD
Time frame: From enrollment to 1 year
The Level of Personality Functioning Scale brief, LPFS-BF2.0
The Level of Personality Functioning Scale brief form, Alternative Model for Personality disorders DSM-5, section iii LPFS-BF2.0 questionnaire. Screening tool for personality disorders
Time frame: From enrollment to 1 year
The Mental Health Continuum short form MHC-SF
questionnaire that measure positive mental health and well-being
Time frame: From enrollment to 1 year
Alcohol Use Disorder Identification Test, AUDIT
Questionnaire screening for alcohol harmful use and dependence
Time frame: From enrollment to 1 year
The drug use disorders identification test DUDIT
Questionnaire screening for harmful use and dependence of drugs
Time frame: From enrollment to 1 year
Difficulties in Emotion Regulation Scale short form DERS SF
Questionnaire measuring problems with emotion regulations
Time frame: From enrollment to 1 year
The Cognitive Fusion Questionnaire CFQ
Questionnaire about cognitive fusion. Cognitive fusion refers to becoming so entangled with thoughts that they strongly dominate behavior, emotions, and perception.
Time frame: From enrollment to 1 year
The Bulls Eyes Values Survey scale BEVS
Questionnaire about value congruent behavior. Examening peoples values and how much they are satisfied with reaching those values
Time frame: From enrollment to 1 year
The Process-Based Assessment Tool PBAT
Questionnaire measuring processes and clinical interventions in therapy
Time frame: From enrollment to 1 year
The Five Facet Mindfulness Questionnaire FFMQ
Questionnaire measuring components and structure of mindfulness
Time frame: From enrollment to 1 year
The Self Compassion Scale short form SCS SF
Questionnaire measuring self compassion. Measures of how compassionately a person relates to themselves during periods of difficulty, failure, suffering, or inadequacy.
Time frame: From enrollment to 1 year
EQ-5D-5L
EQ EuroQol 5 D 5 Dimensions 5L 5 Levels. Questionnaire used to measure health-related quality of life (HRQoL).
Time frame: From enrollment to 1 year
The Work and Social Adjustment Scale, WSAS
Questionnaire that measures how much a person's mental or physical health problems are interfering with their ability to function in everyday life
Time frame: From enrollment to 1 year
The Bergen Insomnia Scale, BIS
Questionnaire for measuring insomnia
Time frame: From enrollment to 1 year
The metacognitions questionnaire, MCQ-30
Questionnaire about metacognitive beliefs. The beliefs people have about their own thinking
Time frame: From enrollment to 1 year
Plan to share: No
Started Mar 2026 (actual). Primary completion is estimated for Dec 2028, 33 months after the start.
Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 33 months is above that.
Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sorlandet Hospital HF